However, PSA testing does not differentiate between potentially fatal and non-fatal prostate cancer, and the vast majority of men with localized disease diagnosed in the PSA era are treated unnecessarily for non-life-threatening cancers [2]. Here, KLK3 is linked to prostate cancer.